Catalog

Contact Hour(s): 

2 Contact hours, including 2 Advanced Pharmacology Hours

Author:

Heather Rhodes, APRN-BC

Sandi Winston, MSN, RN

This peer-reviewed course is applicable for the following professions:

Advanced Practice Registered Nurse (APRN), CCI Credentialed Specialists, Certified Nurse Practitioner, Certified Registered Nurse Anesthetist (CRNA), Clinical Nurse Specialist (CNS), Licensed Practical Nurse (LPN), Licensed Vocational Nurses (LVN), Nursing Student, Occupational Therapist (OT), Occupational Therapist Assistant (OTA), Physical Therapist (PT), Physical Therapist Assistant (PTA), Registered Nurse (RN), Registered Nurse Practitioner, Respiratory Care Practitioner, Respiratory Therapist (RT)

Accreditations: 

The American Nurses Credentialing Center (ANCC), The American Occupational Therapy Association (AOTA), New York State Education Department's State Board for Physical Therapy

State Approvals:

Alabama, Provider #ABNP1485; California BRN Provider #CEP # 13509; Florida Physical Therapy Association Approval: CE26-909414; Kentucky Board of Nursing Provider #7-0085; Florida Board of Nursing Provider 50-353; New York State Education Department’s State Board for Physical Therapy

Course Description:

Dementia is a chronic or progressive syndrome caused by various brain illnesses that affect behavior, memory, thinking, and the ability to perform everyday activities. This course is designed to educate providers on current management techniques for two major neurocognitive disorders that share similar symptoms: Alzheimer's disease and dementia.

Outcomes:

≥ 92% of participants will be able to explain the differences between Alzheimer’s Dementia and vascular dementia.

Objectives:

After completing this continuing education course, the participant will be able to:

1. Explain the difference between Alzheimer's disease and Dementia.
2. Differentiate early, middle and late findings associated with dementia in the assessment of the patient.
3. Identify three causes of reversible dementia.
4. Incorporate three non-drug interventions for a dementia patient who develops behavioral problems.
5. Outline the risk and benefits of drugs used to treat behavioral disturbances in dementia.
6. Relate the challenges in caregiving of a dementia patient.

Disclosures:

CEUFast Inc. and the course planning team for this educational activity do not have any relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

Contact Hour(s): 

1 Contact Hour including 1 Advanced Pharmacology Hour

Authors:

Alyssa King, DNP, APRN, CPNP-PC, PMHNP-BC, PMH-C, CLC, CNE

This peer-reviewed course is applicable for the following professions:

Advanced Practice Registered Nurse (APRN), Athletic Trainer (AT/AL), Certified Nurse Midwife, Certified Nurse Practitioner, Certified Registered Nurse Anesthetist (CRNA), Certified Registered Nurse Practitioner, Clinical Nurse Specialist (CNS), Licensed Practical Nurse (LPN), Licensed Vocational Nurses (LVN), Midwife (MW), Nursing Student, Occupational Therapist (OT), Occupational Therapist Assistant (OTA), Physical Therapist (PT), Physical Therapist Assistant (PTA), Registered Nurse (RN), Registered Nurse Practitioner

Accreditations: 

The American Nurses Credentialing Center (ANCC), The American Occupational Therapy Association (AOTA), Board of Certification for Athletic Trainers (BOC)

State Approvals: 

Alabama, Provider #ABNP1485; California BRN Provider #CEP # 13509; Florida Physical Therapy Association Approval: CE26-1189744; Kentucky Board of Nursing Provider #7-0085; Florida Board of Nursing Provider 50-353; Nevada Board of Physical Therapy; New York State Education Department’s State Board for Physical Therapy  

Course Description:

This course discusses the clinical differences between specific types of anxiety disorders, which disorders are more common for children or adolescents versus those more common in adulthood, the screening tools available for identifying anxiety, and the management and treatment for anxiety disorders. This course will also pay special attention to providing helpful tools that can be utilized to minimize symptoms of anxiety.

Course Outcome:

≥ 92% of participants will know how to assess for and manage anxiety disorders.

Objectives:

After completing this continuing education course, the participant will be able to:

1. Define anxiety and the physical symptoms that are commonly experienced.
2. Compare and contrast the common anxiety disorders diagnosed across the lifespan.
3. Determine how assessing for anxiety in children and adolescents may be different than in adults.
4. List the screening tools utilized for anxiety disorders.
5. Explain the management and treatment of anxiety disorders.
6. Outline the various helpful tools that can be used to minimize symptoms of anxiety.

Disclosures:

CEUFast Inc. and the course planning team for this educational activity do not have any relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

Contact Hour(s): 

2.0 Contact Hours including 2.0 Advanced Pharmacology Hours

Author:

Dana Bartlett, RN, BSN, MA, MA, CSPI

This peer-reviewed course is applicable for the following professions:

Advanced Practice Registered Nurse (APRN), Certified Nurse Midwife, Certified Nurse Practitioner, Certified Registered Nurse Anesthetist (CRNA), Certified Registered Nurse Practitioner, Clinical Nurse Specialist (CNS), Licensed Practical Nurse (LPN), Licensed Vocational Nurses (LVN), Nursing Student, Registered Nurse (RN), Registered Nurse Practitioner

Accreditations: 

The American Nurses Credentialing Center (ANCC)

State Approvals:

Alabama, Provider #ABNP1485; California BRN Provider #CEP #13509; Kentucky Board of Nursing Provider #7-0085; Florida Board of Nursing Provider 50-353

Course Description:

This course discusses the labeled uses, forms, and adverse effects of atypical antipsychotics. It also includes an explanation of long-acting injectable versions of atypical antipsychotics as well as the nursing considerations that must be kept in mind when caring for a patient being prescribed atypical antipsychotics.

Course Outcome:

≥ 92% of participants will be able to identify the uses, forms, and possible adverse effects of atypical antipsychotic medications.

Objectives:

After completing this continuing education course, the participant will be able to:

1. Describe the labeled uses of atypical antipsychotics.
2. Analyze the adverse effects that can result from taking atypical antipsychotics.
3. Identify the rationale for utilizing long-acting injectable forms of atypical antipsychotics.
4. Describe the body’s reaction to abrupt discontinuation of atypical antipsychotics.
5. Explain the monitoring that must be considered when caring for a patient prescribed atypical antipsychotics.

Disclosures:

CEUFast Inc. and the course planning team for this educational activity do not have any relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

Contact Hour(s): 

2 Contact Hours, including 2 Pharmacology Hours

Author:

Lisa Onega, PhD, RN, MBA, FNP-BC, PMHNP-BC, GNP-BC, CNS-BC

This peer-reviewed course is applicable for the following professions:

Advanced Practice Registered Nurse (APRN), Certified Nurse Midwife, Certified Nurse Practitioner, Certified Registered Nurse Practitioner, Clinical Nurse Specialist (CNS), Licensed Practical Nurse (LPN), Licensed Vocational Nurses (LVN), Midwife (MW), Nursing Student, Occupational Therapist (OT), Occupational Therapist Assistant (OTA), Physical Therapist (PT), Physical Therapist Assistant (PTA), Registered Nurse (RN)

Accreditations: 

The American Nurses Credentialing Center (ANCC), The American Occupational Therapy Association (AOTA)

State Approvals:

Alabama, Provider #ABNP1485; California BRN Provider #CEP # 13509; Florida Physical Therapy Association Approval: CE26-1124126; Kentucky Board of Nursing Provider #7-0085; Florida Board of Nursing Provider 50-353; Nevada Board of Physical Therapy; New York State Education Department’s State Board for Physical Therapy

Course Description:

Differential diagnosis of delirium, dementia, and depression is challenging because the presentations of each condition may have overlapping symptoms.  However, accurate diagnosis leads to improved outcomes for individuals and their family members.  The purpose of this course is to present epidemiological factors, characteristics, screening tools, diagnosis, and pharmacological and nonpharmacological treatment for each condition, along with considerations and guidelines to aid in differential diagnosis.  The information will then be applied to determine the diagnosis of an 84-year-old woman, who displays some symptoms associated with each condition.

Outcomes:

≥ 92% of participants will be able to differentiate between presentations of delirium, dementia, and depression in older adults.

Objectives:

After completing this continuing education course, the participant will be able to:

1. Discuss epidemiological factors associated with delirium, dementia, and depression.
2. Examine the characteristics of the presentations for each condition.
3. Identify common screening tools that can be used for each condition.
4. Discuss diagnostic criteria for delirium, dementia, and depression.
5. Analyze pharmacological and nonpharmacological treatment for each condition.
6. Determine considerations and guidelines for differential diagnosis.
7. Apply principles of differential diagnosis to a case.

Disclosures:

CEUFast Inc. and the course planning team for this educational activity do not have any relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

Contact Hour(s): 

2 Contact Hours including 2 Advanced Pharmacology Hours

Author: 

Heather Rhodes, APRN-BC

This peer-reviewed course is applicable for the following professions:

Advanced Practice Registered Nurse (APRN), Athletic Trainer (AT/AL), Clinical Nurse Specialist (CNS), Dietetic Technicians, Registered (DTR), Dietitian/Nutritionist (RDN), Licensed Practical Nurse (LPN), Licensed Vocational Nurses (LVN), Nursing Student, Occupational Therapist (OT), Occupational Therapist Assistant (OTA), Physical Therapist (PT), Physical Therapist Assistant (PTA), Registered Nurse (RN)

Accreditations: 

The American Nurses Credentialing Center (ANCC), The American Occupational Therapy Association (AOTA), Board of Certification for Athletic Trainers (BOC)

State Approvals:

 Alabama, Provider #ABNP1485; California BRN Provider #CEP # 13509; Florida Physical Therapy Association Approval: CE26-1079336; Kentucky Board of Nursing Provider #7-0085; Florida Board of Nursing Provider 50-353; New York State Education Department’s State Board for Physical Therapy  

Course Description: 

At the end of the course, the learner will be able to explain the difference between each of the eating disorder diagnosis, explain causes for the disorders, identify screening tools for assessment, and the clinical features often found with these disorders. The learner will also be able to discuss various medical complications and treatment options available. Criteria for hospitalization and refeeding syndrome in anorexia nervosa are briefly addressed.

Outcomes: 

≥ 92% of participants will understand the six forms, screening tools, and available treatment options for eating disorders.

Objectives: 

After completing this continuing education course, the participant will be able to:

1. Differentiate between each of the eating disorder diagnoses.
2. Explain the possible causes for eating disorders.
3. Identify the screening tools for assessment for eating disorders.
4. Interpret the clinical features often found with eating disorders.
5. Determine various medical complications associated with eating disorders.
6. Outline the treatment options available for eating disorders.

Disclosures: 

CEUFast Inc. and the course planning team for this educational activity do not have any relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. 

Contact Hour(s): 

1 Contact Hour, including 1 Advanced Pharmacology Hour

Author:

James Wittenauer, RN, MSN, MPA, RN-BC

This peer-reviewed course is applicable for the following professions:

Advanced Practice Registered Nurse (APRN), Certified Nurse Practitioner, Certified Registered Nurse Anesthetist (CRNA), Certified Registered Nurse Practitioner, Clinical Nurse Specialist (CNS), Licensed Practical Nurse (LPN), Licensed Vocational Nurses (LVN), Nursing Student, Occupational Therapist (OT), Occupational Therapist Assistant (OTA), Physical Therapist (PT), Physical Therapist Assistant (PTA), Registered Nurse (RN), Registered Nurse Practitioner

Accreditations: 

The American Nurses Credentialing Center (ANCC), The American Occupational Therapy Association (AOTA)

State Approvals:

Alabama, Provider #ABNP1485; California BRN Provider #CEP # 13509; Florida Physical Therapy Association Approval: CE26-704247; Kentucky Board of Nursing Provider #7-0085; Florida Board of Nursing Provider 50-353; Nevada Board of Physical Therapy; New York State Education Department’s State Board for Physical Therapy

Course Description:

This course discusses ICU psychosis, the signs and symptoms of the disorder, the conditions that may predispose the patient to the disorder, the treatment for the disorder, and the long-term consequences.

Outcomes:

≥ 92% of participants will know how to identify ICU psychosis, including how to treat it and take it seriously.

Objectives:

After completing this continuing education course, the participant will be able to:

1. Define ICU psychosis.
2. Determine contributing factors in developing ICU psychosis.
3. Summarize the signs and symptoms of ICU psychosis.
4. Identify treatments used in the management of ICU psychosis.
5. Explain long-term implications for the patient with ICU psychosis.

Disclosures:

CEUFast Inc. and the course planning team for this educational activity do not have any relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

Contact Hour(s): 

1 Contact Hour including 1 Pharmacology Hour

Author:

Alyssa King, DNP, APRN, CPNP-PC, PMHNP-BC, PMH-C, CLC, CNE

Shelly McDonald, DNP, MSN, RN, PHNC

This peer-reviewed course is applicable for the following professions:

Advanced Practice Registered Nurse (APRN), Certified Nurse Midwife, Certified Nurse Practitioner, Certified Registered Nurse Practitioner, Clinical Nurse Specialist (CNS), Licensed Practical Nurse (LPN), Licensed Vocational Nurses (LVN), Midwife (MW), Nursing Student, Registered Nurse (RN)

Accreditations: 

The American Nurses Credentialing Center (ANCC)

State Approvals:

Alabama, Provider #ABNP1485; California BRN Provider #CEP # 13509; Kentucky Board of Nursing Provider #7-0085; Florida Board of Nursing Provider 50-353

Course Description:

This course discusses mental illness during pregnancy, the signs and symptoms of specific disorders, the various risks and complications if they are left untreated or undertreated, and potential treatments that are available.

Course Outcome:

≥ 92% of participants will know how to recognize mental illness and the specific concerns during pregnancy.

Objectives:

After completing this continuing education course, the participant will be able to:

1. Define mental illness during pregnancy.
2. Identify the signs and symptoms of mental illness during pregnancy.
3. Interpret the risks and complications of mental illness during pregnancy.
4. Explain the recommended treatment for patients with mental illness during pregnancy.
5. Describe the appropriate nursing care for the woman with mental illness during pregnancy.

Disclosures:

CEUFast Inc. and the course planning team for this educational activity do not have any relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

Contact Hour(s): 

1.5 Contact Hours, including 1.5 Pharmacology Hours

Author:

Alyssa King, DNP, APRN, CPNP-PC, PMHNP-BC, PMH-C, CLC, CNE

This peer-reviewed course is applicable for the following professions:

Advanced Practice Registered Nurse (APRN), Athletic Trainer (AT/AL), Certified Nurse Midwife, Certified Nurse Practitioner, Certified Registered Nurse Practitioner, Clinical Nurse Specialist (CNS), Licensed Practical Nurse (LPN), Licensed Vocational Nurses (LVN), Midwife (MW), Nursing Student, Occupational Therapist (OT), Occupational Therapist Assistant (OTA), Physical Therapist (PT), Physical Therapist Assistant (PTA), Registered Nurse (RN), Registered Nurse Practitioner

Accreditations: 

The American Nurses Credentialing Center (ANCC), The American Occupational Therapy Association (AOTA), Board of Certification for Athletic Trainers (BOC)

State Approvals:

Alabama, Provider #ABNP1485; California BRN Provider #CEP # 13509; Florida Physical Therapy Association Approval: CE26-1301938; Kentucky Board of Nursing Provider #7-0085; Florida Board of Nursing Provider 50-353; Kentucky Board of Licensure for Occupational Therapy; Nevada Board of Physical Therapy; New York State Education Department’s State Board for Physical Therapy

This course discusses the definitions of terms associated with perinatal mood and anxiety disorders (PMADs), the risk factors that increase a woman’s chance of PMADs, the impact that undiagnosed and untreated PMADs have on children, the signs and symptoms, diagnosis, and treatment of postpartum depression and anxiety, a thorough differentiation of postpartum obsessive compulsive disorder (OCD) versus postpartum psychosis, and our role as nurses in the care of postpartum mothers with PMADs.

Outcomes:

≥ 92% of participants will know how to recognize postpartum depression and anxiety.

Objectives:

After completing this continuing education course, the participant will be able to:

1. Define terminology related to the perinatal period.
2. Identify the signs and symptoms of postpartum depression and anxiety.
3. Determine the screening tools that can be utilized for identifying potential postpartum depression and anxiety.
4. Outline the recommended treatment options for postpartum depression and anxiety.
5. Differentiate postpartum obsessive-compulsive disorder (OCD) from postpartum psychosis.
6. Explain the nurse’s role in caring for postpartum mothers with or at risk for perinatal mood and anxiety disorders (PMADs).

Disclosures:

CEUFast Inc. and the course planning team for this educational activity do not have any relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

Contact Hour(s): 

2 Contact Hours including 2 Advanced Pharmacology Hours

Author:

Mariya Rizwan, PharmD

This peer-reviewed course is applicable for the following professions: 

Advanced Practice Registered Nurse (APRN), Certified Nurse Midwife, Certified Nurse Practitioner, Certified Registered Nurse Anesthetist (CRNA), Certified Registered Nurse Practitioner, Clinical Nurse Specialist (CNS), Licensed Practical Nurse (LPN), Licensed Vocational Nurses (LVN), Midwife (MW), Nursing Student, Registered Nurse (RN), Registered Nurse Practitioner

Accreditations: 

The American Nurses Credentialing Center (ANCC)

Course Description:

This course discusses antipsychotic medications, including their mechanisms of action, receptor targets, and clinical indications across various psychiatric conditions such as anxiety, depression, attention deficit hyperactivity disorder, schizophrenia, bipolar disorder, and psychosis. Participants will gain insight into standard dosing guidelines and routes of administration to optimize therapeutic outcomes. Special considerations for prescribing in older adults, individuals with hepatic or renal impairment, and during pregnancy and breastfeeding will be discussed to ensure safe and effective treatment. The course also covers common and serious side effects of antipsychotic medications, along with crucial safety precautions and contraindications.

Outcomes:

≥ 92% of participants will know about psychopharmacology and medications used for mental health conditions.

Objectives:

After completing this continuing education course, the participant will be able to:

1. Describe the mechanisms of action of various psychopharmacological medications.
2. List the available medicinal forms of psychopharmacological medications and their clinical uses.
3. Outline standard doses and routes for psychopharmacological medications.
4. Summarize contraindications and cautions when prescribing psychopharmacological medications.
5. Identify the side effects of psychopharmacological medications.

Disclosures:

CEUFast Inc. and the course planning team for this educational activity do not have any relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

Contact Hour(s): 

2 Contact Hours including 2 Advanced Pharmacology Hours

Author:

Raymond Lengel, MSN, FNP-BC, RN

This peer-reviewed course is applicable for the following professions: 

Advanced Practice Registered Nurse (APRN), Certified Nurse Practitioner, Certified Registered Nurse Anesthetist (CRNA), Certified Registered Nurse Practitioner, Clinical Nurse Specialist (CNS), Licensed Practical Nurse (LPN), Licensed Vocational Nurses (LVN), Nursing Student, Registered Nurse (RN), Registered Nurse Practitioner

Accreditations: 

The American Nurses Credentialing Center (ANCC)

Course Description:

This course discusses neurobiology, clinical manifestations, therapeutic interventions, and the lived experiences of individuals grappling with schizophrenia.

Outcomes:

≥ 92% of participants will know how to appropriately care for patients with schizophrenia.

Objectives:

After completing this continuing education course, the participant will be able to:

1. Describe the neurobiology of schizophrenia.
2. Outline the clinical manifestations of schizophrenia.
3. Explain the diagnostic workup of the patient with schizophrenia.
4. Identify medications used to treat schizophrenia.
5. Describe the side effects of medications used to treat schizophrenia.

Disclosures:

CEUFast Inc. and the course planning team for this educational activity do not have any relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

Contact Hour(s): 

6 Contact hours, including 6 Advanced Pharmacology Hours

Author:

Melissa Decapria, DNP, PMHNP-BC

This peer-reviewed course is applicable for the following professions:

Advanced Practice Registered Nurse (APRN), Certified Nurse Midwife, Certified Nurse Practitioner, Certified Registered Nurse Anesthetist (CRNA), Clinical Nurse Specialist (CNS), Licensed Practical Nurse (LPN), Licensed Vocational Nurses (LVN), Nursing Student, Occupational Therapist (OT), Occupational Therapist Assistant (OTA), Other, Physical Therapist (PT), Physical Therapist Assistant (PTA), Registered Nurse (RN), Registered Nurse Practitioner, Respiratory Care Practitioner, Respiratory Therapist (RT)

Accreditations:

The American Nurses Credentialing Center (ANCC)

State Approvals:

Alabama, Provider #ABNP1485; California BRN Provider #CEP # 13509; Florida Physical Therapy Association Approval: CE26-767443; Kentucky Board of Nursing Provider #7-0085; Florida Board of Nursing Provider 50-353; New York State Education Department’s State Board for Physical Therapy

Course Description:

This course offers suicide prevention training for healthcare professionals. Participants will learn how to screen, assess and manage suicidal thoughts, plans, and behaviors.

Outcomes:

≥ 92% of participants will know how to assess, treat, and manage suicidal thoughts, plans, and behaviors.

Objectives:

After completing this continuing education course, the participant will be able to:

1. Recall terms that describe suicidal thinking and behavior.
2. Define both suicide risk factors and protective factors.
3. Differentiate suicide risk screening and assessments.
4. Describe the current prevalence of suicide rates compared with other major causes of death.
5. Identify the major risk factors for suicide.
6. Differentiate between high-risk and low-risk characteristics.
7. Define parasuicidality.
8. Distinguish lethal means from self-injurious behaviors.
9. Outline how to complete a comprehensive suicide assessment.
10. Identify psychiatric signs and symptoms that increase a person's suicide risk.
11. Describe the appropriate treatment and management of suicidal behaviors.
12. Summarize how to determine the treatment setting following a suicide attempt or aborted suicide attempt.
13. Recognize when and how to document suicidal thoughts, plans, and behaviors in order to mitigate risk and prevent malpractice lawsuits.
14. Illustrate the increased need for suicide prevention in the veteran population.
15. Relate non-pharmacological interventions' role in the management of depression.
16. Discuss the safety and efficacy of different antidepressant medications.

Disclosures:

CEUFast Inc. and the course planning team for this educational activity do not have any relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.